Monitor for tachycardia and hypertension. Further evaluate patients who develop exertional chest pain, unexplained syncope, or arrhythmias during Mydayis treatment.ĬNS stimulants cause increased blood pressure (mean increase ~2-4 mm Hg) and heart rate (mean increase ~3-6 bpm). Sudden death, stroke and myocardial infarction have been reported in adults with CNS stimulants at recommended doses, as well as sudden death in pediatric patients with structural cardiac abnormalities and other serious heart problems while taking CNS stimulants at recommended doses. Use with monoamine oxidase inhibitors (MAOIs) or within 14 days of last MAOI dose, due to increased risk of hypertensive crisis.Īvoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart arrhythmia, coronary artery disease, and other serious heart problems. Angioedema and anaphylactic reactions have been reported with other amphetamines. Known hypersensitivity to amphetamines or other ingredients of Mydayis. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
![i doser doses description i doser doses description](https://skyvapharmaceuticals.com/wp-content/uploads/2020/03/pa7.jpg)
Pharmacological treatment of ADHD may be needed for an extended period. Doses higher than 25 mg have not been evaluated in clinical trials in pediatric patients. Dose should be individualized according to the needs and response of the patient. Dosage may be adjusted in increments of 12.5 mg, no sooner than weekly, up to recommended max dose 25 mg/day. Doses above 50 mg/day have shown no additional clinically meaningful benefit.įor pediatric patients (ages 13-17 years), the recommended starting dose is 12.5 mg once daily in the morning upon awakening. Dosage may be adjusted in increments of 12.5 mg, no sooner than weekly, up to a max 50 mg/day, based on therapeutic needs and response of the patient. Initial doses of 25 mg once daily may be considered for some adult patients. For adult patients, the recommended starting dose of Mydayis is 12.5 mg once daily in the morning upon awakening.